患教专员/患者教育专员（北京）
赛纽仕医药咨询（上海）有限公司
- 公司规模：500-1000人
- 公司性质：外资（欧美）
- 公司行业：制药/生物工程
职位信息
- 发布日期：2023-12-16
- 工作地点：北京
- 工作经验：1年
- 学历要求：大专
- 职位月薪：7千-1万
- 职位类别：护士/护理人员
职位描述
提供所负责区域罕见病患者的健康宣教；
指导罕见病患者疾病的家庭护理
定期开展患教会，协助患者了解当地医保政策，指导其进行相关援助项目申请岗位要求：护理专业背景，有护士执业资格证；
大专以上学历；能适应短期出差，需具备一定抗压能力；
有患者管理，临床经验丰富者优先
职能类别：
护士/护理人员
关键字：
护理健康宣教医保政策家庭护理患者管理
指导罕见病患者疾病的家庭护理
定期开展患教会，协助患者了解当地医保政策，指导其进行相关援助项目申请岗位要求：护理专业背景，有护士执业资格证；
大专以上学历；能适应短期出差，需具备一定抗压能力；
有患者管理，临床经验丰富者优先
职能类别：
护士/护理人员
关键字：
护理健康宣教医保政策家庭护理患者管理
公司介绍
About Syneos Health
Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
* We expect Syneos Health common shares to trade on the Nasdaq Global Select Market under the new name and new ticker symbol “SYNH” by January 9, 2018. Until then, Syneos Health will continue to be listed under INC Research Holdings, Inc. and the symbol “INCR.”
FOR USE AFTER JANUARY 9
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
* We expect Syneos Health common shares to trade on the Nasdaq Global Select Market under the new name and new ticker symbol “SYNH” by January 9, 2018. Until then, Syneos Health will continue to be listed under INC Research Holdings, Inc. and the symbol “INCR.”
FOR USE AFTER JANUARY 9
About Syneos Health
Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit ****************.
联系方式
- 公司地址：上海市静安区南京西路688号506室 (邮编：200041)